Spots Global Cancer Trial Database for Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.
Official Title: A Phase III Randomized Multicenter Study,Comparing an Induction Chemotherapy Followed by Irradiation and Concurrent Erbitux Versus Chemoradiotherapy for Patients With Locoregional Advanced Head and Neck Cancers
Study ID: NCT01233843
Conditions
Study Description
Brief Summary: The purpose of this study is to demonstrate that induction chemotherapy followed by radiation therapy plus Cetuximab will give better results than the validated treatment (chemoradiotherapy), for treatment of locoregional advanced head and neck cancers.
Detailed Description: Concurrent chemoradiotherapy (radiotherapy+ carboplatin + 5FU) is a validated treatment for patients with locoregional advanced head and neck cancers. This study evaluates the outcome of induction chemotherapy (docetaxel, cisplatin, 5 FU) followed by radiation therapy + Erbitux for patients with head and neck carcinoma with almost one measurable lesion by RMI or CT scan. We hope we can improve the progression free survival of 14% at two years .
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GIRARD CALAIS Marie-Helene, Tours, , France
Contact Details
Name: Lionnel GEOFFROIS, oncologist
Affiliation: Centre Alexis Vautrin NANCY France
Role: STUDY_DIRECTOR
Name: Etienne BARDET, oncologist
Affiliation: Centre Rene Gauducheau NANTES France
Role: PRINCIPAL_INVESTIGATOR
Name: Christian SIRE, oncologist
Affiliation: Hopital de Bretagne Sud LORIENT France
Role: PRINCIPAL_INVESTIGATOR
Name: Laurent MARTIN, oncologist
Affiliation: Centre Guillaume le Conquerant LE HAVRE France
Role: PRINCIPAL_INVESTIGATOR
Name: Jean-Marc TOURANI, oncologist
Affiliation: CHU POITIERS France
Role: PRINCIPAL_INVESTIGATOR
Name: Philippe MAINGON, oncologist
Affiliation: Centre Georges Francois Leclerc
Role: PRINCIPAL_INVESTIGATOR
Name: Ayman ZAWADI, oncologist
Affiliation: CHD de Vendee LA ROCHE SUR YON France
Role: PRINCIPAL_INVESTIGATOR
Name: François GUICHARD, oncologist
Affiliation: Polyclinique de BORDEAUX NORD France
Role: PRINCIPAL_INVESTIGATOR
Name: Anne-Françoise DILLIES, oncologist
Affiliation: Centre Jean Perrin CLERMONT FERRAND France
Role: PRINCIPAL_INVESTIGATOR
Name: Dominique De RAUCOURT, oncologist
Affiliation: Centre François Baclesse CAEN France
Role: PRINCIPAL_INVESTIGATOR
Name: Emmanuel BABIN, oncologist
Affiliation: Hopital Cote de Nacre CAEN France
Role: PRINCIPAL_INVESTIGATOR
Name: Claude TUCHAIS, oncologist
Affiliation: Centre Paul Papin ANGERS France
Role: PRINCIPAL_INVESTIGATOR
Name: XU SHAN Sun, oncologist
Affiliation: Hopital Emile Muller MULHOUSE France
Role: PRINCIPAL_INVESTIGATOR
Name: Nicolas MEERT, oncologist
Affiliation: Grand Hôpital de Charleroi Belgique
Role: PRINCIPAL_INVESTIGATOR
Name: Anne-Rose HENRY, oncologist
Affiliation: CHU André Vésale MONTIGNY Belgique
Role: PRINCIPAL_INVESTIGATOR
Name: Cedrik LAFOND, oncologist
Affiliation: Centre Jean Bernard LE MANS France
Role: PRINCIPAL_INVESTIGATOR
Name: Thierry PIGNON, oncologist
Affiliation: Centre Saint Louis TOULON France
Role: PRINCIPAL_INVESTIGATOR
Name: Ali HASBINI, oncologist
Affiliation: Clinique Armoricaine SAINT BRIEUC France
Role: PRINCIPAL_INVESTIGATOR
Name: Jean BOURHIS, oncologist
Affiliation: Institut Gustave Roussy VILLEJUIF France
Role: PRINCIPAL_INVESTIGATOR
Name: Marie SALIOU, oncologist
Affiliation: Centre Etienne Dolet SAINT NAZAIRE France
Role: PRINCIPAL_INVESTIGATOR
Name: Alexandre COUTTE, oncologist
Affiliation: CHU sud AMIENS France
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
